Sanh Monica, Holbrook Anne, Macdonald Peter D M, Lee Justin
, PharmD, ACPR, is a Clinical Pharmacist with the University Health Network, Toronto, Ontario.
, MD, PharmD, MSc, FRCPC, is a Clinical Pharmacologist and Internal Medicine Specialist with St Joseph's Healthcare Hamilton, and a Professor in the Department of Medicine and Director of the Division of Clinical Pharmacology and Toxicology, McMaster University, Hamilton, Ontario.
Can J Hosp Pharm. 2022 Jul 4;75(3):219-224. doi: 10.4212/cjhp.3122. eCollection 2022 Summer.
High-cost health care users use disproportionate amounts of health care resources relative to the typical patient. It is unclear to what extent poor-quality prescribing, including potentially inappropriate prescribing (PIP), may be contributing to their adverse outcomes and health utilization costs.
To evaluate the prevalence of PIP and to explore its impact in older adult high-cost health care users.
The charts of older adult high-cost health care users admitted to 2 academic hospitals in Ontario, Canada, in fiscal year 2015/16 were reviewed. Eligible patients were at least 66 years old with at least 5 emergency department visits and 3 hospital admissions in the previous year. A total of 243 patients met these criteria, of whom 100 were randomly selected for review. Cases of PIP were identified using explicit prescribing quality indicators, including the STOPP/START criteria. Types of PIP included potentially inappropriate medications (PIMs) and potential prescribing omissions (PPOs). Log-linear regression was used to characterize the relationship between PIP and future health care utilization. Medications were reconciled to determine the proportion of PIP addressed by the time of discharge.
Eighty-nine of the 100 patients had at least 1 instance of PIP. In total, 276 PIMs and 54 PPOs were identified. Of the 271 instances of PIP identified on admission, only 38 (14%) were resolved by the time of hospital discharge. Each additional PPO was associated with a 1.43-fold increase in the rate of future emergency department visits ( < 0.001).
The rate of PIP among older adult high-cost health care users was high. Despite frequent interactions with the health care system, many opportunities to improve the quality of prescribing for this vulnerable population were missed. Greater attention to medication optimization is needed.
与普通患者相比,高成本医疗使用者消耗了不成比例的医疗资源。目前尚不清楚包括潜在不适当处方(PIP)在内的低质量处方在多大程度上可能导致了他们的不良后果和医疗使用成本。
评估潜在不适当处方的患病率,并探讨其对老年高成本医疗使用者的影响。
回顾了2015/16财政年度加拿大安大略省两家学术医院收治的老年高成本医疗使用者的病历。符合条件的患者年龄至少66岁,前一年至少有5次急诊就诊和3次住院。共有243名患者符合这些标准,其中100名被随机选择进行审查。使用明确的处方质量指标(包括STOPP/START标准)识别潜在不适当处方的病例。潜在不适当处方的类型包括潜在不适当药物(PIMs)和潜在处方遗漏(PPOs)。使用对数线性回归来描述潜在不适当处方与未来医疗使用之间的关系。核对药物以确定出院时解决的潜在不适当处方的比例。
100名患者中有89名至少有1例潜在不适当处方。总共识别出276种潜在不适当药物和54种潜在处方遗漏。在入院时识别出的271例潜在不适当处方中,到出院时只有38例(14%)得到解决。每增加一例潜在处方遗漏,未来急诊就诊率就会增加1.43倍(P<0.001)。
老年高成本医疗使用者中潜在不适当处方的发生率很高。尽管与医疗系统有频繁互动,但改善这一弱势群体处方质量的许多机会都被错过了。需要更加关注药物优化。